Did These Stocks Miss or Beat Analyst Expectations?

AngioDynamics Inc. (NASDAQ:ANGO) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 36.36% to $0.07 in the quarter versus EPS of $0.11 in the year-earlier quarter. Revenue Rose 56.01% to $90 million from the year-earlier quarter.

AngioDynamics Inc. reported adjusted EPS income of $0.07 per share. By that measure, the company beat the mean analyst estimate of $0.06. It beat the average revenue estimate of $86.43 million.

ANGO

Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.06 in the quarter versus EPS of $-0.10 in the year-earlier quarter. Revenue Rose 105.31% to $4.25 million from the year-earlier quarter.

Peregrine Pharmaceuticals Inc. reported adjusted EPS loss of $0.06 per share. By that measure, the company met the mean analyst estimate of $-0.06. It beat the average revenue estimate of $3.57 million.

PPHM

Hi Tech Pharmacal Co. Inc. (NASDAQ:HITK) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 31.51% to $0.50 in the quarter versus EPS of $0.73 in the year-earlier quarter. Revenue Decreased 4.55% to $58.5 million from the year-earlier quarter.

Hi Tech Pharmacal Co. Inc. reported adjusted EPS income of $0.50 per share. By that measure, the company missed the mean analyst estimate of $0.63. It missed the average revenue estimate of $66.33 million.

HITK

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet